Skip to main content
The BMJ logoLink to The BMJ
letter
. 1993 Mar 27;306(6881):860. doi: 10.1136/bmj.306.6881.860

Screening for hypertrophic cardiomyopathy.

G R McLatchie, D S Pedoe, W J McKenna, C Butler, W S Hillis, G Davies, T Yorath, M J Davies, J F Goodwin
PMCID: PMC1677278  PMID: 8490401

Full text

PDF

Page 860

860

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clark A. L., Coats A. J. Screening for hypertrophic cardiomyopathy. BMJ. 1993 Feb 13;306(6875):409–410. doi: 10.1136/bmj.306.6875.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. McKenna W. J., Camm A. J. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation. 1989 Nov;80(5):1489–1492. doi: 10.1161/01.cir.80.5.1489. [DOI] [PubMed] [Google Scholar]
  3. McKenna W. J., Oakley C. M., Krikler D. M., Goodwin J. F. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J. 1985 Apr;53(4):412–416. doi: 10.1136/hrt.53.4.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Saumarez R. C., Camm A. J., Panagos A., Gill J. S., Stewart J. T., de Belder M. A., Simpson I. A., McKenna W. J. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation. 1992 Aug;86(2):467–474. doi: 10.1161/01.cir.86.2.467. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES